Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT):Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.Int J Hematol,105:623-630, 2017.
Arai H, Tajiri M, Kaneko S, Kushida Y, Ando K, Tachibana T, Umeda S, Okudela K, Komatsu S, Masuda M:Two surgical cases of thymic MALT lymphoma associated with multiple lung cysts: possible association with Sjögren’s syndrome.Gen Thorac Cardiovasc Surg,65(4):229-234, 2017.
Arakaki H, Nakazato T, Osada Y, Ito C, Aisa Y and Mori T: Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma.Ann Hematol,96(7): 1225-1226, 2017.
Doki N, Kakihana K, Ashizawa M, Onoda M, Ohwada C, Kobayashi S, Gotoh M, Fujisawa S, Okamoto S, for the Kanto Study Group for Cell Therapy Clinical characteristics of calcineurin inhibitor-induced pain syndrome (CIPS) after allogeneic hematopoietic stem cell transplantation. Journal of Hematopoietic Cell Transplantation,6:115-119.2017.
Fujisawa S, Mizuta S, Akiyama H, Ueda Y, Aoyama Y, Hatta Y, Kakihana K, Dobashi N, Sugiura I, Onishi Y, Maeda T, Imai K, Ohtake S, Miyazaki Y, Ohnishi K, Matsuo K, Naoe T:Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.
Am J Hematol,92:367-374, 2017.
Hayakawa T, Nonaka T, Mizoguchi N, Hagiwara Y, Shibata S, Sakai R, Nakayama N, Yokose T and Nakayama Y:Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the rectum: a case report.
Clin J Gastroenterol, 10(5): 431-436, 2017.
Iriyama N, Tokuhira M, Takaku T, Sato E, Ishikawa M, Nakazato T, Sugimoto
KJ, Fujita H, Fujioka I, Hatta Y, Kizaki M, Komatsu N, Asou N, Kawaguchi T:
Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group.
Leuk Res, 54:55-58, 2017.
Kako S, Kanda Y, Kato J, Yamamoto W, Kato S, Onizuka M, Yokota A, Tatara R, Yokoyama H, Hagihara M, Usuki K, Gotoh M, Watanabe R, Kawai N, Saitoh T, Kanamori H, Takahashi S, Okamoto S:The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS.
Hematol Oncol,35(3):341-349, 2017.
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M:Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Leukemia, 31(3):663-668, 2017.
Kawamura K, Kako S, Mizuta S, Ishiyama K, Aoki J, Yano S, Fukuda T, Uchida N, Ozawa Y, Eto T, Iwato K, Kanamori H, Kahata K, Kondo T, Sawa M, Ichinohe T, Atsuta Y, Kanda Y:Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older. Biol Blood Marrow Transplant,23:2079-2087.2017.
Kimura S, Fujita H, Kato H, Hiramoto N, Hosono N, Takahashi T, Shigeno K, Hatsumi N, Minamiguchi H, Miyatake J, Handa H, Akiyama N, Kanda Y, Yoshida M, Kiyoi H, Miyazaki Y, Naoe T; Japan Adult Leukemia Study Group (JALSG).Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.Support Care Cancer, 25(11):3515-3521, 2017.
Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K.Clinical impact of pre-transplant use of multiple tyrosine kinase inhibitors on the outcome of allo-HSCT for CML.Am J Hematol,92(9):902-908, 2017.
Konuma T, Kondo T, Yamashita T, Uchida N, Fukuda T, Ozawa Y, Ohashi K, Ogawa H, Kato C, Takahashi S, Kanamori H, Eto T, Nakaseko C, Kohno A, Ichinohe T, Atsuta Y, Takami A, Yano S: Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (J SHCT).
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8.Ann Hematol,96(3):469-478, 2017.
Koyama S, Fujisawa S, Watanabe R, Itabashi M, Ishibashi D, Ishii Y, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Yamazaki E, Koharazawa H, Takemura S, Tomita N, Sakai R, Motomura S, Nakajima H:
Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.Int J Lab Hematol,39:112-117, 2017.
Koyama M, Numata A, Ishiyama Y, Takasaki H, Washimi K, Kawachi K, Yokose T, Nakamura N, Sakai R and Nakajima H:Chronic lymphocytic leukemia/small lymphocytic lymphoma with t (2;18) (p12;q21) accompanied by a cutaneous nodule with histological features of diffuse large B-cell lymphoma. Rinsho Ketsueki, 58(7): 749-754, 2017.
Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y.Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic GVHD.Biol Blood Marrow Transplant, 23(10):1749-1758, 2017.
Maruyama D, Nagai H, Maeda Y, Nakane T, Shimoyama T, Nakazato T, Sakai R, Ishikawa T, Izutsu K, Ueda R and Tobinai K:Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma.
Cancer Sci,,108(10): 2061-2068. 2017.
Miura K, Konishi J, Miyake T, Makita M, Hojo A, Masaki Y, Uno M, Ozaki J, Yoshida C, Niiya D, Kitazume K, Maeda Y, Takizawa J, Sakai R, Yano T, Yamamoto K, Sunami K, Hiramatsu Y, Aoyama K, Tsujimura H, Murakami J, Hatta Y and Kanno M:A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.Oncologist, 22(5): 554-560, 2017.
Miyazaki Y, Naoe T:Japan Adult Leukemia Study Group (JALSG).
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.Support Care Cancer.,25(11):3515-3521, 2017.
Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Chou T, Uchiyama H, Ohashi K, Miyamoto T, Ozawa Y, Imataki O, Kobayashi N, Uchida N, Kanamori H, Kamimura T, Eto T, Onizuka M, Tanaka J, Atsuta Y, Yano S: Comparison of autologous and unrelated transplants for cytogenetically normal acute myeloid leukemia.Biol Blood Marrow Transplant,23(9):1447-1454, 2017
Mori J, Yanada M, Uchida N, Fukuda T, Sakura T, Hidaka M, Watakabe-Inamoto K, Kanamori H, Ogawa H, Ichinohe T, Tanaka J, Atsuta Y, Yano S:
Outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with abnormalities of the short arm of chromosome 17.
Biol Blood Marrow Transplant,23(8):1398-1404, 2017.
Nakamae H, Fujisawa S, Ogura M, Uchida T, Onishi Y, Taniwaki M, Utsunomiya A, Matsue K, Takamatsu Y, Usuki K, Tanimoto M, Ishida Y, Ohashi K, Li L, Miyoshi M.Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report. Int J Hematol,105:792-804, 2017.
Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T, Ueda Y, Mori T, Hashimoto H, Ogawa H, Eto T, Ueki T, Miyamoto T, Ichinohe T, Atsuta Y, Fukuda T, on behalf of the Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation.Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant,52(11):1563-1570, 2017.
Osada Y, Arakaki H, Takanashi S, Ito C, Aisa Y and Nakazato T:Association
between a cardiovascular disease risk assessment and the molecular response to tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia patients.
Med Oncol, 34(4): 66, 2017.
Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, Ogusa E, Koyama S, Numata A, Tomita N, Taguchi J, Fujisawa S, Kanamori H, Nakajima H:Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.Leuk Lymphoma,58:1403-1411, 2017.
Tachibana T, Nakayama N, Matsumura A, Nakajima Y, Takahashi H, Miyazaki T, Nakajima H:Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera.Interm Med,56:2487-2492, 2017
Takanashi S, Aisa Y, Ito C, Arakaki H, Osada Y, Amano Y, Hirano M and Nakazato T:Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.Rheumatol Int, 37(10): 1629-1633, 2017.
Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi s, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T:Graft-versus-host disease prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adult with acute leukemia.
Bone Marrow Transplant,52(9):1261-1267, 2017.
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T for the Japan Society for the Hematopoietic Cell Transplantation GVHD working group.Exploratory research for optimal GVHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe graft-versus-host disease more than mycophenolate mofetil.Bone Marrow Transplant,52(3):423-430, 2017.
Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E, Hirase C, Takeshita A, Imai K, Okumura H, Morishita Y, Usui N, TakahaFujisawa S S, Shiraishi Y, Chiba K, Tanaka H, Kiyoi H, Ohnishi K, Ohtake S, Asou N, Kobayashi Y, Miyazaki Y, Miyano S, Ogawa S, Matsumura I, Nakaseko C and Naoe T:Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.Blood Cancer J,7:e559, 2017.
Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H,
Kobayashi N, Sawa M, Nakamae H, Uchida N, Hashimoto H, Fukuda T, Hirokawa H, Atsuta Y, Yano S: Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study.Bone Marrow Transplant ,52:818-824, 2017.
Yanada M, Yano S, Kanamori H, Gotoh M, Emi N, Watakabe K, Kurokawa M, Nishikawa A, Mori T, Tomita N, Murata M, Hashimoto H, Henzan H, Kanda Y, Sawa M, Kohno A, Atsuta Y, Ichinohe T, Takami A:Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission after the introduction of arsenic trioxide.Leuk Lymphoma,58:1061-1067, 2017.
Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S:Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia.Ann Hematol,96:289-297, 2017.
Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y:Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.Leuk Lymphoma,58:104-109, 2017.
Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Fukunaga K, Wakita S, Ryotokuji T, Fukuda T, Inokuchi K:D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.Ann Hematol,96:1641-1652, 2017.
Asou N, Fujita H, Shinagawa K:JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL). Int J Hematol.,106(4):459-470, 2017.
Nakajima H:Guest editorial: Hematopoietic stem cells. Int J Hematol,106:15-17,2017
